Oligonucleotide Drugs for Transthyretin Amyloidosis

David Adams, Philip N. Hawkins, Michael J Polydefkis

Research output: Contribution to journalLetter

Original languageEnglish (US)
Number of pages1
JournalThe New England journal of medicine
Volume379
Issue number21
DOIs
StatePublished - Nov 22 2018

Fingerprint

Oligonucleotides
Pharmaceutical Preparations
Amyloidosis, Hereditary, Transthyretin-Related

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Oligonucleotide Drugs for Transthyretin Amyloidosis. / Adams, David; Hawkins, Philip N.; Polydefkis, Michael J.

In: The New England journal of medicine, Vol. 379, No. 21, 22.11.2018.

Research output: Contribution to journalLetter

@article{0a075e21070246949c10fe2386fd8c14,
title = "Oligonucleotide Drugs for Transthyretin Amyloidosis",
author = "David Adams and Hawkins, {Philip N.} and Polydefkis, {Michael J}",
year = "2018",
month = "11",
day = "22",
doi = "10.1056/NEJMc1810994",
language = "English (US)",
volume = "379",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "21",

}

TY - JOUR

T1 - Oligonucleotide Drugs for Transthyretin Amyloidosis

AU - Adams, David

AU - Hawkins, Philip N.

AU - Polydefkis, Michael J

PY - 2018/11/22

Y1 - 2018/11/22

UR - http://www.scopus.com/inward/record.url?scp=85057523088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057523088&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1810994

DO - 10.1056/NEJMc1810994

M3 - Letter

C2 - 30484624

AN - SCOPUS:85057523088

VL - 379

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 21

ER -